QR Pharma Announces Publication on Posiphen Clincial Trials Showing Promise
Read more here
News
TREVENTIS Corporation Scientific Founder, Named Sobey Chair in Alzheimer’s Disease Research
Read more here
Ceptaris Secures $10 Million in Series D-1 Financing
Read more here
Niiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO
Read more here
Galleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression
Read more here
FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients
Read more here
Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent
Read more here
Niiki Pharma to Present Preclinical Results, Start Testing Cancer Drug
Read more here
QR Pharma Has a Gut Feeling about Parkinson’s
Read more here
QR Pharma Awarded Funding by Michael J. Fox Foundation to Test Posiphen® as a Treatment for Parkinson’s Disease
Read more here